Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Susan A, Galel"'
Autor:
Michelle S. Chevalier, Brad J. Biggerstaff, Sridhar V. Basavaraju, M. Cheryl Bañez Ocfemia, Jose O. Alsina, Consuelo Climent-Peris, Robin R. Moseley, Koo-Whang Chung, Brenda Rivera-García, Melissa Bello-Pagán, Lisa L. Pate, Susan A. Galel, Phillip Williamson, Matthew J. Kuehnert
Publikováno v:
Emerging Infectious Diseases, Vol 23, Iss 5, Pp 790-795 (2017)
Puerto Rico has been heavily impacted by Zika virus, a mosquitoborne flavivirus that emerged in the Americas during 2015. Although most persons with Zika virus show no symptoms, the virus can cause neurologic and other complications, including fetal
Externí odkaz:
https://doaj.org/article/e8dbdecfce6545c6bec95f936aea293c
Autor:
Phillip C. Williamson, Steven Kleinman, Lisa Lee Pate, Brad J. Biggerstaff, Jose Alsina, Christina M. Newman, Mars Stone, Graham Simmons, Gerardo Latoni, Susan A. Galel, Michael P. Busch, Sonia Bakkour, Val Winkelman
Publikováno v:
The Lancet Infectious Diseases. 20:1437-1445
Summary Background Puerto Rico began screening blood donations for Zika virus RNA with nucleic acid amplification tests (NAATs) on April 3, 2016, because of an emerging Zika virus outbreak. We followed up positive donors to assess the dynamics of vir
Autor:
Lisa Lee Pate, Tzong-Hae Lee, Phillip C. Williamson, Zhanna Kaidarova, Marion C. Lanteri, Steve Kleinman, Graham Simmons, Michael P. Busch, Roberta Bruhn, Jose Alsina, Susan A. Galel, Mars Stone, Sonia Bakkour, Donald Brambilla, Jeffrey M. Linnen
Publikováno v:
Lancet Infect Dis
Summary Background Characterisation of the dynamics of Zika virus persistence following acute infection is needed to inform blood donor and diagnostic testing policies and understand the natural history of Zika virus infection. We aimed to characteri
Autor:
Susan L. Stramer, Lisa Lee Pate, Susan N. Rossmann, Yasuko Erickson, Jean Stanley, Susan A. Galel, Mark Janzen, Jed B. Gorlin, Patrick Albrecht, Julie Cruz, Todd Straus
Publikováno v:
Transfusion. 61(10)
Background Human babesiosis is a zoonotic infection caused by an intraerythrocytic parasite. The highest incidence of babesiosis is in the United States, although cases have been reported in other parts of the world. Due to concerns of transfusion-tr
Publikováno v:
Monoclonal Antibodies, Cytokines, and Arthritis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b66a4891de892dba130c81118b0e68eb
https://doi.org/10.1201/9781003066255-4
https://doi.org/10.1201/9781003066255-4
Autor:
Viroje Chongkolwatana, Susan L. Stramer, Nguyen Thi Thanh Dung, Anyarin Pojanasingchod, Jean Stanley, Susan A. Galel, Pham Tuan Duong, Pimpun Kitpoka, Kacie Grimm, Panitita Suksomboonvong
Publikováno v:
Transfusion
Background Chikungunya (CHIKV), dengue (DENV), and Zika (ZIKV) viruses are of concern due to the potential of transfusion transmission in blood, especially in regions such as Southeast Asia where the viruses are endemic. The recent availability of nu
Autor:
Lisa Lee Pate, Nancy Huynh, Rasa Bertuzis, Yasuko Erickson, John Duncan, Susan A. Galel, Nicole Dyer, Phillip C. Williamson, Dan A. Waxman, James P. AuBuchon, Jean Stanley
Publikováno v:
Transfusion
Background West Nile virus (WNV) is transmitted to humans through mosquito bites and can be further transmitted to humans through transfusion or transplantation. Because most infected individuals are asymptomatic, blood donor screening is important i
Autor:
Susan L, Stramer, Jean, Stanley, Megan L, Nguyen, Rasa, Bertuzis, Nancy, Huynh, John R, Duncan, Patrick, Albrecht, Lisa L, Pate, Susan A, Galel
Publikováno v:
Transfusion
BACKGROUND Chikungunya (CHIKV) and dengue (DENV) viruses are primarily mosquito‐borne, but transfusion transmission can occur (DENV) or is likely (CHIKV). In the absence of commercially available blood screening assays, a variety of strategies to e
Autor:
Susan A. Galel, Tho D. Pham, Samantha Gomez, Lawrence T. Goodnough, Jan Webster, Magali J. Fontaine
Publikováno v:
Transfusion. 55:2783-2789
BACKGROUND Plasma volume reduction (PVR) may reduce the risk of hemolysis associated with transfusion of plateletpheresis blood products (PLTs) containing ABO-incompatible plasma. But PVR may delay PLT issue. In collaboration with our blood donor cen
Autor:
Susan A, Galel, Toby L, Simon, Phillip C, Williamson, James P, AuBuchon, Dan A, Waxman, Yasuko, Erickson, Rasa, Bertuzis, John R, Duncan, Khushbeer, Malhotra, Jeffrey, Vaks, Nancy, Huynh, Lisa Lee, Pate
Publikováno v:
Transfusion. 58(3)
Use of nucleic acid testing (NAT) in donor infectious disease screening improves transfusion safety. Advances in NAT technology include improvements in assay sensitivity and system automation, and real-time viral target discrimination in multiplex as